Serum levels of tumour necrosis factor alpha and other cytokines do not correlate with weight loss and anorexia in cancer patients

Supportive Care in Cancer

Volumn 5, Issue 2, 1997, Pages 130-135

  Maltoni, Marco ^a   Fabbri, Laura ^a   Nanni, Oriana ^b   Scarpi, Emanuela ^b   Pezzi, Laura ^a   Flamini, Emanuela ^a   Riccobon, Angela ^a   Derni, Stefania ^a   Pallotti, Gualtiero ^a   Amadori, Dino ^a  

^a Ospedale Pierantoni   (Italy)

^b ISTITUTO ONCOLOGICO ROMAGNOLO   (Italy)

Author keywords

Anorexia; Cachexia; Cancer; Interferon; Interleukin; tumour necrosis factor

Indexed keywords

CD20 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CREATININE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; BLOOD LEVEL; CACHEXIA; CANCER PATIENT; FEMALE; HOST RESISTANCE; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PROGNOSIS; TERMINAL DISEASE; WEIGHT REDUCTION;

EID: 12644298682     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01262570     Document Type: Article

References (31)

1. Aderka D, Fisher S, Levo Y, Holtmann H, Hahn T, Wallach D (1985) Cachectin/tumor necrosis factor production by cancer patients. Lancet II:1190
2. Alexander HR, Norton JA (1993) Pathophysiology of cancer cachexia. In: Doyle D, Hanks GWC, Macdonald N (eds) Oxford textbook of palliative medicine. Oxford University Press, Oxford, pp 316-329
3. Balkwill F, Osborne R, Burke F, Naylor S, Talbot D, Durbin H, Tavernier J, Fiers W (1987) Evidence for tumor necrosis factor/cachectin production in cancer. Lancet II:1229-1231
4. Beck SA, Mulligan HD, Tisdale MJ (1990) Lipolytic factors associated with murine and human cancer cachexia. J Natl Cancer Inst 82:1922-1926
5. Bendtzen K (1988) Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. Immunol Lett 19:183-192
6. Bruera E, Fainsinger RL (1993) Clinical management of cachexia and anorexia. In: Doyle D, Hanks GWC, Macdonald N (eds) Oxford Textbook of Palliative Medicine. Oxford University Press, Oxford, pp 330-337
7. Butler LD, Layman NK, Cain RL, Riedl PE, Mohler KM, Bobbit JL, Belagajie R (1989) Interleukin 1-induced pathophysiology: induction of cytokines, development of histopathologic changes and immunopharmacologic intervention. Clin Immunol Immunopathol 53:400-421
8. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666-3670
9. De Wys WD, Begg C, Lavin PT, et al (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69:491-497
10. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, Figari IS, Palladino MA Jr, O'Connor JV (1986) Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 163:1433-1450
11. Espat NJ, Copeland EM, Moldawer LL (1994) Tumour necrosis factor and cachexia: a current perspective. Surg Oncol 3:255-262
12. Gatanaga T, Hwang CD, Kohr W, Cappuccini F, Lucci JA, Jeffes EW, Lentz R, Tomich J, Yamamoto RS, Granger GA (1990) Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients. Proc Natl Acad Sci USA 87:8781-8784
13. Gemlo BT, Palladino MA, Jaffe HS, Espevik TP, Rayner AA (1988) Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells. Cancer Res 48:5864-5867
14. Havell EA (1992) Role of TNF in resistance to bacteria. Immunol Ser 56:341-363
15. Kern KA, Norton JA (1988) Cancer cachexia. J Parenter Enter Nutr 12:286-298
16. Langstein HN, Fraker DL, Norton JA (1989) Reversal of cancer cachexia by antibodies to interferon-gamma but not cachectin/tumor necrosis factor. Surg Forum 15:408-410
17. Maltoni M, Pirovano M, Scarpi E, Marinari M, Indelli M, Arnoldi E, Gallucci M, Frontini L, Piva L, Amadori D (1995) Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study. Cancer 75:2613-2622
18. Moldawer LL, Drott C, Lundholm K (1988) Monocytic production and plasma bioactivities of interleukin 1 and tumor necrosis factor in human cancer. Eur J Clin Invest 18:486-492
19. Mori M, Yamaguchi K, Kaoru R (1989) Purification of a lipoprotein lipase-inhibiting protein produced by a melanoma cell line associated with cancer cachexia. Biochem Biophys Res Commun 160:1085-1092
20. Nelson KA, Walsh D, Sheehan FA (1994) The cancer anorexia-cachexia syndrome. J Clin Oncol 12:213-225
21. Oliff A (1988) The role of tumor necrosis factor (cachectin) in cachexia. Cell 54:141-142
22. Reuben DB, Mor V, Hiris J (1988) Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med 148:1586-1591
23. Scuderi P, Sterling KE, Lam KS, Finley PR, Ryan KJ, Ray CG, Petersen E, Slymen DJ, Salmon SE (1986) Raised serum levels of tumour necrosis factor in parasitic infections. Lancet 11:1364-1365
24. Shery BA, Gelin J, Fong Y, Marano M, Wei H, Cerami A, Lowry SF, Lundholm KG, Moldawer LL (1989) Anticachectin/tumor necrosis factor a antibodies attenuate development of cachexia in tumor models. FASEB J 3:1956-1962
25. Silimes MA, Teppo AM, Koskelo EK, Saarinen UM (1991) Serum tumor necrosis factor does not correlate with changes in muscle volume in children with malignancies. Pediatr Hematol Oncol 8:69-75
26. Socher SH, Martinez D, Craig JB, Kühn JG, Oliff A (1988) Tumor necrosis factor not detectable in patients with clinical cancer cachexia. J Natl Cancer Inst 80:595-598
27. Strassman G, Fong M, Kenney JS, Jacob CO (1992) Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 89:1681-1684
28. Talmadge JE, Bowersox O, Tribble H, Shepard M, Liggitt D (1989) Therapeutic and toxic activity of tumor necrosis factor is synergistic with gamma-interferon. Pathol Immunopathol Res 8:21-34
29. Toomey D, Redmond HP, Bouchier-Hayes D (1995) Mechanisms mediating cancer cachexia. Cancer 76:2418-2426
30. Waage A, Espevik T, Lamvik J (1986) Detection of tumour necrosis factor-like cytotoxicity in serum from patients with septicaemia but not from untreated cancer patients. Scand J Immunol 24:739-743
31. Warren S (1932) The immediate causes of death in cancer. Am J Med Sci 184:610-615